On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayJun 14, 2017 11:36 am

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Announces Launch of New Service Module Targeting Hip and Knee Surgical Procedures

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced the planned launch of its new service module for hip and knee surgical procedures, which is scheduled to take place in July 2017. “The launch of this new module follows the successful launch of our spine module, which for the past eight months has been in continuous use in two nationally recognized hospitals, achieving overwhelming success,” Colt Melby, CEO of ORHub, stated in the news release. “Our hips and knees module is the second of many on our technical road map that will allow us to exponentially grow our addressable…

Continue Reading

WednesdayJun 14, 2017 9:30 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role…

Continue Reading

TuesdayJun 13, 2017 10:06 am

QualityStocksNewsBreaks – Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) Reports Confirmed PATSCAN CMR™ Sales Commitments of $2.7M

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF), developer of the award-winning PATSCAN CMR™ concealed weapons detection system, this morning announced that it has recorded $2.7 million in confirmed sales commitment since commencing product marketing just three months ago ahead of the ISC West trade show in Las Vegas. “Our roll-out program initially conceived finalizing our engineering in early spring in order to meet Industry Canada and FCC certification requirements by late summer,” Dinesh Kandanchatha, president and CTO of Patriot One, stated in the news release. “We have informed our supply chain partners of the accelerating demand, and I am…

Continue Reading

TuesdayJun 13, 2017 9:36 am

QualityStocksNewsBreaks – Converde Energy USA, Inc. (XFUL) Enters Securities Purchase Agreement with GPL Ventures LLC; Retains Minivest as Advisor

Converde Energy USA, Inc. (OTC: XFUL) this morning announced its entry into a securities purchase agreement with GPL Ventures LLC (“GPL”) through which GPL will have the option to purchase up to $3 million in XFUL common stock when the company has qualified the necessary number of shares under Regulation A through an offering statement. Per the update, XFUL intends to file the offering statement within the next 30 days. “We are very excited to have this investment agreement in place as a primary funding vehicle for the company,” Brad Domitrovitsch, chairman and CEO of XFUL, stated in the news…

Continue Reading

TuesdayJun 13, 2017 9:02 am

QualityStocksNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Teams with Pharmaseed to Advance Development of INM-750

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization. Under the terms of this agreement, the Pharmaseed development team will now play a key role in the ongoing development of InMed’s lead compound, INM-750, which is a proprietary, topical cannabinoid product candidate that’s currently being studied as a therapy in epidermolysis bullosa and other potential dermatological and wound-healing applications. “This agreement with Pharmaseed now adds one of Israel's leading formulation development teams to our efforts and represents an important strategic…

Continue Reading

MondayJun 12, 2017 9:01 am

QualityStocksNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Becomes Exclusive Licensee of Cannabis-Based Treatment for Alzheimer’s Disease

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its entry into a definitive license agreement with the University of South Florida that makes the company the exclusive licensee of the U.S. patent filing entitled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’. If the patent filing is granted and proven, IGC anticipates that it could create a “significant therapeutic pathway” in the Alzheimer’s disease market, which is expected to record direct costs in excess of $450 billion annually in the next 12 years. “Securing this…

Continue Reading

FridayJun 09, 2017 10:44 am

QualityStocksNewsBreaks – Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Steps Up Exploration Efforts in Wake of Chinese Production Cuts

As China recently increased its import of zinc in the wake of production halts – part of an environmental crackdown on China’s steel industry – global zinc prices subsequently soared. With worldwide zinc inventories already under pressure due to increasing demand, China’s efforts to curb zinc and nickel production will likely continue significantly impacting the global supply, and zinc exploration corporations like Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) are hastening to step up their efforts to find deposits and help slake this global shortage. “China’s move is likely to drive zinc demand even higher. According to the International Lead…

Continue Reading

ThursdayJun 08, 2017 1:27 pm

QualityStocksNewsBreaks – Grey Cloak Tech (GRCK) Enables Integration of Brick-and-Mortar and E-Commerce Omni-Channel Shopping

Now a dual-faceted company following its March 2017 takeover of ShareRails and its cloud-based software, Grey Cloak Tech (OTC: GRCK) is poised to play a significant role as major retailers seek to successfully integrate their physical stores with e-commerce to keep stride with the changing retail market. The proprietary software offered through ShareRails presents a promising solution in the battle of brick-and-mortar stores versus online companies, enabling storefront merchants to compete in the omni-channel shopping world and drive business to their physical locations through the use of e-commerce tools. “ShareRails’ proprietary software could be a key element in the survival…

Continue Reading

WednesdayJun 07, 2017 3:17 pm

QualityStocksNewsBreaks – Player’s Network (PNTV) Shares Continue Two-Day Streak, Set Second New High this Week

Shares of Player’s Network (OTCQB: PNTV) are up 7% at $0.10 near market close, moving on volume of 5.83 million and setting a new 52-week high for the third time since last Friday. On June 2, PNTV announced (http://dtn.fm/G2ewZ) that its majority owned Green Leaf Farms subsidiary had completed the first phase of construction for its marijuana cultivation and production facility in North Las Vegas. This achievement was preceded by news earlier in the week that Green Leaf received two Nevada state-issued recreational marijuana licenses, as well as medical marijuana licenses (http://dtn.fm/pr4DB). PNTV said the licenses create another revenue stream…

Continue Reading

WednesdayJun 07, 2017 10:18 am

QualityStocksNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Pursues Clinical Trials of Cannabis-Based Combination Therapies with Assistance of New Advisor

India Globalization Capital (NYSE MKT: IGC) recently named Craig Cheifetz, M.D. as an advisor to assist the company with its clinical trials in microbiology, immunology, neuroscience and biotechnology. IGC CEO Ram Mukunda stated in a news release that the company looks forward to Dr. Cheifetz’s contributions as IGC moves forward in the development of unique cannabis combination therapies. “The company anticipates clinical trials in 2017 for several indications, including pain, a huge market. IGC has already filed for six patents in areas such as eating disorders and epilepsy, in addition to pain. It is working on several more filings for…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered